Czechia· CZ-0021698
DEXAMETHASONE WZF POLFA
A dexamethasone product, registered in Czechia by Warszawskie Zaklady Farmaceutyczne Polfa S.A., Varšava. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Dexamethasone is registered in 13 of 19 countries.
Countries holding a registration under ATC S01BA01 (dexamethasone), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Dexamethasone · ATC S01BA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dexamethasone costs, country by country.
Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dexamethasone · price per daily dose (0.2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$362.24
The record
At a glance
SÚKL (Czech Republic)- Manufacturer
- Warszawskie Zaklady Farmaceutyczne Polfa S.A., Varšava
- Country
- Czechia (CZ)
- ATC code
- S01BA01
- ATC class
- Dexamethasone
- Defined daily dose
- 0.2 mg, AT
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- August 24, 2026
Packs & prices · 1
1 priced- cz_kod_sukl00216981X5MLCZK 176.46
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
96 interactions on record for dexamethasone.
Graded by severity as the source publishes them — 41 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexamethasone · interactions on record
96 records
- 41 moderate
- 55 minor
Most severe, free to view
- MiconazoleA07AC01moderate
- LonafarnibA16AX20moderate
- VoxelotorB06AX03moderate
- ConivaptanC03XA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under S01BA01
Dexamethasone, as other registers publish it.
- NetherlandsAxium-Opto 1mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A
- FinlandAxiumoptoUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
- DenmarkAxiumoptoUNI-Pharma Kleon
- BelgiumDarazon 1 mg/mlPharmaselect International Beteiligungs
- PolandDarazurPharmaselect International Beteiligungs GmbH
- CzechiaDARAZURPharmaselect International Beteiligungs GmbH, Vídeň
- CzechiaDARAZURPharmaselect International Beteiligungs GmbH, Vídeň
- PolandDemezonSun-Farm Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c83191fd-cd4f-41ad-abfe-65d16209f2fd GET /v1/drugs/c83191fd-cd4f-41ad-abfe-65d16209f2fd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "OPH GTT SUS",
"source": "sukl",
"strength": "1MG/ML",
"pack_size": "1X5ML",
"substance": "451",
"cz_kod_sukl": "0021698",
"product_type": "CH",
"registration_state": "B",
"registration_number": "64/160/90-C"
}See everything about dexamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.